Insilico Medicine is a Baltimore-based company utilizing advances in
genomics and big data analysis for in silico drug discovery and drug
repurposing for aging and age-related diseases. The company uses the
GeroScopeâ„¢ and OncoFinderâ„¢ packages for aging and cancer research.
Through internal expertise and extensive collaborations with brilliant
scientists, institutions, and highly credible pharmaceutical companies,
Insilico Medicine seeks to discover new drugs and drug combinations for
personalized preventative medicine. For more information on Insilico
Medicine, Inc. please visit http://www.insilicomedicine.com.